SHANGHAI MEDICILON INC. revenue breakdown overview

SHANGHAI MEDICILON INC. revenue for the last year amounted to 1.37 B CNY, the most of which — 733.80 M CNY — came from its highest performing source at the moment, Preclinical Research, the year earlier bringing 923.63 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI MEDICILON INC. 978.16 M CNY, and the year before that — 1.26 B CNY.